-
1
-
-
70350449070
-
Immunohistochemical prognostic indicators of lymphoma tumors
-
Alsheyab F, Abbas M, Mosameh Y, Ali S (2009). Immunohistochemical prognostic indicators of lymphoma tumors. Afr. J. Biotechnol. 8(19): 5025-5029.
-
(2009)
Afr. J. Biotechnol
, vol.8
, Issue.19
, pp. 5025-5029
-
-
Alsheyab, F.1
Abbas, M.2
Mosameh, Y.3
Ali, S.4
-
2
-
-
34147216138
-
A high throughput luminescent assay for glycogen synthase kinase-3_ inhibitors
-
Baki A, Bielik A, Molnár L, Szendrei G, Keserü GM (2007). A high throughput luminescent assay for glycogen synthase kinase-3_ inhibitors. Assay Drug Dev. Technol. 5(1): 75-83.
-
(2007)
Assay Drug Dev. Technol
, vol.5
, Issue.1
, pp. 75-83
-
-
Baki, A.1
Bielik, A.2
Molnár, L.3
Szendrei, G.4
Keserü, G.M.5
-
3
-
-
33645856488
-
Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury
-
Bonnans C, Fukunaga K, Keledjian R, Petasis NA, Levy BD (2006). Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury. J. Exp. Med. 203: 857-863.
-
(2006)
J. Exp. Med
, vol.203
, pp. 857-863
-
-
Bonnans, C.1
Fukunaga, K.2
Keledjian, R.3
Petasis, N.A.4
Levy, B.D.5
-
4
-
-
31544439637
-
A novel mass spectrometry-based assay for GSK-3beta activity
-
Bowley E, Mulvihill E, Howard JC, Pak BJ, Gan BS, O'Gorman DB (2005). A novel mass spectrometry-based assay for GSK-3beta activity. BMC Biochem. 16(6): 29-37.
-
(2005)
BMC Biochem
, vol.16
, Issue.6
, pp. 29-37
-
-
Bowley, E.1
Mulvihill, E.2
Howard, J.C.3
Pak, B.J.4
Gan, B.S.5
O'Gorman, D.B.6
-
5
-
-
68049148602
-
A method to measure trace enzyme based on microchip capillary electrophoresis
-
Cong H, Wang HM, Ju SQ, Jin QH, Jia CP, Song HW (2009). A method to measure trace enzyme based on microchip capillary electrophoresis. Prog. Inorg. Biochem. Biophys. 36(4): 512-516.
-
(2009)
Prog. Inorg. Biochem. Biophys
, vol.36
, Issue.4
, pp. 512-516
-
-
Cong, H.1
Wang, H.M.2
Ju, S.Q.3
Jin, Q.H.4
Jia, C.P.5
Song, H.W.6
-
6
-
-
67849119262
-
The CDK inhibitor, R-roscovitine, promotes eosinophil apoptosis by down-regulation of Mcl-1
-
Duffin R, Leitch AE, Sheldrake TA, Hallett JM, Meyer C, Fox S, Alessandri AL, Martin MC, Brady HJ, Teixeira MM, Dransfield I, Haslett C, Rossi AG (2009). The CDK inhibitor, R-roscovitine, promotes eosinophil apoptosis by down-regulation of Mcl-1. FEBS Lett. 583(15): 2540-2546.
-
(2009)
FEBS Lett
, vol.583
, Issue.15
, pp. 2540-2546
-
-
Duffin, R.1
Leitch, A.E.2
Sheldrake, T.A.3
Hallett, J.M.4
Meyer, C.5
Fox, S.6
Alessandri, A.L.7
Martin, M.C.8
Brady, H.J.9
Teixeira, M.M.10
Dransfield, I.11
Haslett, C.12
Rossi, A.G.13
-
7
-
-
33751114158
-
Oxygen alters caveolin-1 and nitric oxide synthase-3 functions in ovine fetal and neonatal lung microvascular endothelial cells
-
John TA, Ibe BO, Raj JU (2006). Oxygen alters caveolin-1 and nitric oxide synthase-3 functions in ovine fetal and neonatal lung microvascular endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 291: 1079-1093.
-
(2006)
Am. J. Physiol. Lung Cell Mol. Physiol
, vol.291
, pp. 1079-1093
-
-
John, T.A.1
Ibe, B.O.2
Raj, J.U.3
-
8
-
-
33947585184
-
Screening of drugs that suppress Ste11 MAPKKK activation in yeast identified a c-Abl tyrosine kinase inhibitor
-
Kitagawa T, Hashizume Y, Murakane T, Koga E, Nomura Y, Kakihare Y, Fujied A, Uchida M, Takahashi H, Hoshida H, Akada R (2007). Screening of drugs that suppress Ste11 MAPKKK activation in yeast identified a c-Abl tyrosine kinase inhibitor. Biosci. Biotechnol. Biochem. 71: 772-782.
-
(2007)
Biosci. Biotechnol. Biochem
, vol.71
, pp. 772-782
-
-
Kitagawa, T.1
Hashizume, Y.2
Murakane, T.3
Koga, E.4
Nomura, Y.5
Kakihare, Y.6
Fujied, A.7
Uchida, M.8
Takahashi, H.9
Hoshida, H.10
Akada, R.11
-
9
-
-
8844239191
-
NMR backbone assignment of a protein kinase catalytic domain by a combination of several approaches: Application to the catalytic subunit of cAMP-dependent protein kinase
-
Langer T, Vogtherr M, Elshorst B, Betz M, Schieborr U, Saxena K, Schwalbe H (2004). NMR backbone assignment of a protein kinase catalytic domain by a combination of several approaches: application to the catalytic subunit of cAMP-dependent protein kinase. Chem. Biochem. 5: 1508-1516.
-
(2004)
Chem. Biochem
, vol.5
, pp. 1508-1516
-
-
Langer, T.1
Vogtherr, M.2
Elshorst, B.3
Betz, M.4
Schieborr, U.5
Saxena, K.6
Schwalbe, H.7
-
10
-
-
60749109846
-
Cell cycle, CDKs and cancer: A changing paradigm
-
Malumbres M, Barbacid M (2009). Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer, 9(3): 153-166.
-
(2009)
Nat. Rev. Cancer
, vol.9
, Issue.3
, pp. 153-166
-
-
Malumbres, M.1
Barbacid, M.2
-
11
-
-
34147192707
-
Identification of small molecule ceramide kinase inhibitors using a homogeneous chemiluminescence high throughput assay
-
Munagala N, Nguyen S, Lam W, Lee J, Joly A, McMillan K, Zhang W (2007). Identification of small molecule ceramide kinase inhibitors using a homogeneous chemiluminescence high throughput assay. Assay Drug Dev. Technol. 5: 65-73.
-
(2007)
Assay Drug Dev. Technol
, vol.5
, pp. 65-73
-
-
Munagala, N.1
Nguyen, S.2
Lam, W.3
Lee, J.4
Joly, A.5
McMillan, K.6
Zhang, W.7
-
12
-
-
35448956881
-
Finishing mitosis, one step at a time
-
Sullivan M, Morgan DO (2007). Finishing mitosis, one step at a time. Nat. Rev. Mol. Cell Biol. 8(11): 894-903.
-
(2007)
Nat. Rev. Mol. Cell Biol
, vol.8
, Issue.11
, pp. 894-903
-
-
Sullivan, M.1
Morgan, D.O.2
-
13
-
-
77954571810
-
CDK inhibitors as potential breast cancer therapeutics: New evidence for enhanced efficacy in ER+ disease
-
Sutherland RL, Musgrove EA (2009). CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ disease. Breast Cancer Res. 11: 112-113.
-
(2009)
Breast Cancer Res
, vol.11
, pp. 112-113
-
-
Sutherland, R.L.1
Musgrove, E.A.2
-
14
-
-
23944455114
-
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system
-
Tagliati F, Bottoni A, Bosetti A, Zatelli MC, Ettore Uberti CD (2005). Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system. J. Pharm. Biomed. Anal. 39: 811-814.
-
(2005)
J. Pharm. Biomed. Anal
, vol.39
, pp. 811-814
-
-
Tagliati, F.1
Bottoni, A.2
Bosetti, A.3
Zatelli, M.C.4
Ettore Uberti, C.D.5
-
15
-
-
62549157391
-
Induction of apoptosis and cell proliferation inhibition by paclitaxel in FM3A cell cultures
-
Ugar NN, African GÖ (2009). Induction of apoptosis and cell proliferation inhibition by paclitaxel in FM3A cell cultures. Afr. J. Biotechnol. 8(4): 547-555.
-
(2009)
Afr. J. Biotechnol
, vol.8
, Issue.4
, pp. 547-555
-
-
Ugar, N.N.1
African, G.Ö.2
-
16
-
-
76449101999
-
SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway
-
Xie G, Zhu X, Li Q, Gu MH, He ZJ, Wu JH, Li J, Lin YC, Li MF, She ZG, Yuan J (2010). SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway. Br. J. Pharamacol. 159(3): 689-697.
-
(2010)
Br. J. Pharamacol
, vol.159
, Issue.3
, pp. 689-697
-
-
Xie, G.1
Zhu, X.2
Li, Q.3
Gu, M.H.4
He, Z.J.5
Wu, J.H.6
Li, J.7
Lin, Y.C.8
Li, M.F.9
She, Z.G.10
Yuan, J.11
-
17
-
-
41549156919
-
Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: Brachydactyly type C and proximal symphalangism
-
Yang W, Cao LH, Liu W, Jiang L, Sun M, Zhang D, Wang S, Lo WH, Luo Y, Zhang X (2008). Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism. J. Hum. Genet. 53(4): 368-374.
-
(2008)
J. Hum. Genet
, vol.53
, Issue.4
, pp. 368-374
-
-
Yang, W.1
Cao, L.H.2
Liu, W.3
Jiang, L.4
Sun, M.5
Zhang, D.6
Wang, S.7
Lo, W.H.8
Luo, Y.9
Zhang, X.10
|